Funder
National Institute of Diabetes and Digestive and Kidney Diseases
National Center for Advancing Translational Sciences
Reference36 articles.
1. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity;Browning;Hepatology,2004
2. Design and validation of a histological scoring system for nonalcoholic fatty liver disease;Kleiner;Hepatology,2005
3. Case definitions for inclusion and analysis of endpoints in clinical trials for NASH through the lens of regulatory science;Shadab Siddiqui;Hepatology,2017
4. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial;Neuschwander-Tetri;Lancet,2015
5. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c;Watanabe;J Clin Invest,2004
Cited by
100 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献